Log In
Print
BCIQ
Print
Print this Print this
 

Oral Recosulin (Generex Oral-lyn)

Also known as: Oral-lyn, insulin (Oralgen, Oralin)

  Manage Alerts
Collapse Summary General Information
Company Generex Biotechnology Corp.
DescriptionBuccal spray insulin delivered via RapidMist technology
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat impaired glucose tolerance associated with pre-diabetes; Treat postprandial hyperglycemia; Treat Type I and Type II diabetes; Treat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner

Dong Sung Pharmaceutical Co. Ltd.; Shreya Life Sciences Pvt. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today